NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
263 hedge funds and large institutions have $2.65B invested in NuVasive, Inc. in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 85 increasing their positions, 102 reducing their positions, and 50 closing their positions.
5% more call options, than puts
Call options by funds: $31.8M | Put options by funds: $30.5M
9% less funds holding
Funds holding: 290 → 263 (-27)
17% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 102
17% less capital invested
Capital invested by funds: $3.21B → $2.65B (-$558M)
50% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 50
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$24.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$23.1M |
| 3 |
Barclays
London,
United Kingdom
|
+$21M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$19.5M |
| 5 |
Holocene Advisors
New York
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$54M |
| 2 |
Goldman Sachs
New York
|
-$47.1M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$28.4M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$20.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.4M |
NUVA Hedge Fund Activity: Q3 2020 in Review
263 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q3 2020, worth a combined $2.65B — down 17% from $3.21B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of NUVA and 25 opened new positions — a net loss of 25 holders — while 102 trimmed existing stakes and 85 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $24.2M. The largest seller was HealthCor Management, exiting entirely with an estimated $54M sold.
- 263 institutional investors held NuVasive, Inc. (NUVA) as of Q3 2020, down from 290 in Q2 2020.
- Funds reported $2.65B of NuVasive, Inc. stock for Q3 2020, down 17% quarter-over-quarter.
- 25 funds opened new NuVasive, Inc. positions in Q3 2020 and 50 closed out, a net change of -25 holders.
- The largest NuVasive, Inc. buyer in Q3 2020 was Armistice Capital, an estimated $24.2M added.
- The largest NuVasive, Inc. seller in Q3 2020 was HealthCor Management, an estimated $54M sold.
Based on aggregated 13F filings for Q3 2020.